GOLDEN, CO / ACCESS Newswire / June 10, 2025 / Vitro Biopharma Inc. today announced that its AlloRx stem cell therapy was prominently featured in a New York Times article discussing the future of ...
The abstract highlights Be Biopharma’s approach using both in vitro and in vivo assays to determine the potential of B Cell Medicines (BCMs) as an allogeneic off-the-shelf cell therapy without ...
This flagship event is set to converge 800+ global leaders and pioneers in biologics, biosimilars, cell-based technologies, advanced in-vitro models, New Approach Methodologies (NAMs), and ...